Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy
{{output}}
Platinum-induced myelosuppression severely impedes successful chemotherapy in non-small-cell lung cancer (NSCLC) patients. Hence, it is clinically important to identify the patients who are at high risk for severe toxicity to certain chemotherapy. We first car... ...
